ECMO breakthrough? major trial aims to cut deadly complications
NCT ID NCT06526533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing different treatments to reduce major complications and improve survival in 600 adults who need ECMO—a machine that does the work of the heart and lungs. Researchers will compare how well these treatments work in the first 28 days. The goal is to find safer, more effective ways to care for critically ill patients on ECMO.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Prince Alfred Hospital
NOT_YET_RECRUITINGCamperdown, New South Wales, 2050, Australia
-
St. Vincent's Hospital Sydney
RECRUITINGSydney, New South Wales, 2010, Australia
-
The Alfred Hospital
NOT_YET_RECRUITINGMelbourne, Victoria, 3004, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Blood test may forecast brain recovery after cardiac arrest
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- A gentle touch from family may calm the ICU storm
- Can a High-Tech CPR bundle boost heart restart rates?